Medidata to Offer DCT Platform
Medidata, a Dassault Systèmes company, has announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, a comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum. Drug, vaccine, and medical device developers (sponsors) and contract research organizations (CROs) can take advantage of the platform offering on the market which combines:
- Technology and workflows to virtualize patient participation
- Tools that facilitate sponsor oversight of patient safety and data quality
- Direct-to-patient services, including facilitation of delivery of study drugs to the home
To date, Medidata has applied its decentralizing technologies across more than 44,000 clinical sites around the world in multiple languages involving more than 600,000 patients with a wide array of illnesses.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
